期刊文献+

布地奈德联合综合护理治疗小儿肺炎疗效观察 被引量:2

Observation on Curative Effect of Budesonide Combined With Comprehensive Nursing for Children Pneumonia
下载PDF
导出
摘要 目的探讨布地奈德雾化吸入联合综合护理治疗小儿肺炎的临床疗效。方法选取本院小儿肺炎患儿82例(2017年1月—2018年10月),随机分为综合护理的观察组(41例)与常规护理的对照组(41例),患儿均给予布地奈德雾化吸入治疗,观察患儿临床症状改善情况、肺功能改善情况。结果观察组退热时间(3.9±1.4)d、咳嗽缓解时间(5.1±1.2)d、肺部啰音消失时间(7.5±1.3)d,与对照组相比,P<0.05,观察组FVC(2.79±0.23)L,FEV1(2.12±0.48)L,FEV1/FVC(62.48%±8.16%),与对照组相比,P<0.05。结论在小儿肺炎患儿布地奈德雾化吸入治疗的同时配合综合护理,能改善患儿临床症状及肺功能指标,促进身体恢复,取得了较好的效果。 Objective To explore the clinical effect of budesonide nebulization combined with comprehensive nursing in the treatment of pediatric pneumonia.Methods 82 children with pediatric pneumonia in our hospital(from January 2017 to October 2018)were randomly divided into the observation group under comprehensive care(41 cases)and the control group under routine care(41 cases).All children were treated with budesonide atomization inhalation,and the improvement of clinical symptoms and pulmonary function were observed.Results The feverreducing time(3.9±1.4)d,cough remission time(5.1±1.2)d,and lung RRR disappearance time(7.5±1.3)d in the observation group were significantly longer than those in the control group(P<0.05).FVC(2.79±0.23)L,FEV1(2.12±0.48)L,FEV1/FVC(62.48%±8.16%)in the observation group were significantly longer than those in the control group(P<0.05).Conclusion Combined with comprehensive nursing care,budesonide aerosol inhalation therapy for children with pneumonia can improve the clinical symptoms and pulmonary function indicators of children,promote the recovery of the body,and achieve good results.
作者 辛英 XIN Ying(Department of Pediatrics,Macheng People's Hospital,Macheng Hubei 438300,China)
出处 《中国继续医学教育》 2020年第8期189-191,共3页 China Continuing Medical Education
关键词 布地奈德雾化吸入 综合 小儿肺炎 临床效果 临床症状 肺功能 budesonide aerosol inhalation comprehensive pediatric pneumonia clinical effect clinical symptoms pulmonary function
  • 相关文献

参考文献13

二级参考文献136

  • 1迟明,李静.微生态制剂在儿童肠道疾病的应用进展[J].中国微生态学杂志,2006,18(1):80-80. 被引量:25
  • 2韩宇.微生态制剂治疗肝硬化肠功能紊乱患者的临床观察[J].中国微生态学杂志,2007,19(1):74-74. 被引量:14
  • 3胡亚美 江载芳.诸福棠实用儿科学[M]第7版[M].北京:人民卫生出版社,2002.1514.
  • 4Mosbah AA, Abdellatif NA, Sorour El, et al. Serum SP-D levels as a biomarker of lung injury in children suffering of bronchopneumonia[J]. J Egypt Soc Parasitol, 2012,42 ( 1 ) : 25-32.
  • 5Lamm CG, Love BC, Krehbiel CR, et al. Comparison of antemortem antimicrobial treatment regimens to antimicrobial susceptibility patterns of postmortem lung isolates from feedlot cattle with bronchopneumonia[J]. J Vet Diagn Invest, 2012,24(2) : 277-282.
  • 6Turpeinen M, Pelkonen AS, Selroos O, et al. Continuous versus intermittent inhaled corticosteroid (budesonide) for mild persistent asthma in children -- not too much, not too little[J]. Thorax, 2012,67(2) : 100-102.
  • 7Szefler SJ, Carlsson LG, Uryniak T, et al. Budesonide inhalation suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma[J]. J Allergy Clin Immunol Pract,2013,1(1) :58-64.
  • 8Behrman RE,Kliegman RM,Jenson HB.Nelson Textbook of Pediatrics,16th ed. Philadelphia : Saunders . 2001
  • 9Kim YH,Kim JE,Hyun MC.Cytokine response in pediatric patients with pandemic influenza H1N1 2009virus infection andpneumonia:comparison with pediatric pneumonia without H1N1 2009infection[J].Pediatr Pulmonol,2011,46(12):1233-1239.
  • 10Marek SR,Donovan MJ,Smyth HD.Effects of mild processing pressures on the performance of dry powder inhaler formulations for inhalation therapy.1:budesonide and lactose[J].Eur J Pharm Biopharm,2011,78(1):97-106.

共引文献500

同被引文献25

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部